Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Pilot Project for Anal Dysplasia Screening in Women With Cervical or Vulvar Dysplasia

This clinical trial studies colposcopy and high resolution anoscopy in screening for anal dysplasia in patients with cervical, vaginal, or vulvar dysplasia or cancer. Screening may help doctors find cancer cells early and plan better treatment for cancer

OBJECTIVES:

I. To evaluate the risk of anal dysplasia in women with cervical or vulvar dysplasia.

OUTLINE:

Patients undergo colposcopy and cervical Papanicolaou test with Human papillomavirus (HPV) test followed by anal Papanicolaou test and high resolution anoscopy. Patients with dysplastic anal lesions undergo repeat anoscopy at 3, 9, 15, and 24 months. Patients with normal anoscopy are followed up at 1 and 2 years.

Inclusion Criteria:

• Histological confirmation of cervical, vaginal or vulvar intraepithelial neoplasia or cancer are included
• Individuals treated with prior radiation therapy and/or chemotherapy are allowed
• Women with high-grade dysplasia (carcinoma in situ) are eligible, regardless of their dysplasia free interval
• HIV-positive (Human Immunodeficiency Virus) and HIV-negative women will be enrolled; HIV testing will not be performed as part of the study

Exclusion Criteria:

• Women who are not able to consent are excluded